3-[4-(4-Phenyl-1-Butoxy)benzoyl]Amino-2-Hydroxyacetophenone

136450-06-1

Chenglian Pharmaceutical is an innovative high-tech pharmaceu←tical enterprise that is market-oriented and realizes industrial developme®nt through R&D innovation and technology transformation.

key word:

innovative Pharmaceutical

Category:

Consulting
Related

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to build a la→rge health industry finance platform company integrating pharmaceutical, intelligent mεedical, bio pharmaceutical R&D, industrial production and ≤sales.

The chemical reactions involved in the existing products include Foucault reac tion, nitration reaction, sulfonation reaction, hydrogenation reaction, fluorination reactio♦n, chlorination reaction, bromination reaction, diazotization react™ion, format reaction, etc.

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) in‍hibitor developed by Merck. In October 2006, Sitagliptin phosphat≈e Januvia was approved by FDA as the first DPP4 inhibitor for the treatment of typ®e ⅱ diabetes mellitus. The characteristics of this drug are that it can stimulate insulλin secretion while reducing hunger without causing weight gain. Hy∏poglycemia and edema will not occur, and it is suitable for diabetic paΩtients with poor blood glucose control and frequent hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceuti₹cal enterprise that is market-oriented and realizes industrial development through R&D innovation &and technology transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the most important♠ products for the treatment of arthritis. It is well tolerated and has a low incidence of ↑side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major✘ leukotriene receptor antagonists. In clinical applicat∞ion, it has good therapeutic effect on atopic asthma and other types of bronchial≈ asthma, and the market prospect is huge. In the major category of asthmλa drugs, leukotriene receptor antagonists have the fγastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-♠oriented and realizes industrial development through R&D innovation and ↓technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the second drug approved by® FDA for Alzheimer's disease in the United States. Its treatment≠ reaches the target dose and has low toxic and side efγfects. It has been widely recognized by our medical community, and good toler↔ance is its biggest advantage. In October 1999, Donepezil was launched in China under the tr>ade name "Aricept", which is the main chemical drug against Alzheimer's disease. At₹ present, CFDA has approved a number of domestic enterprises to produce donepezil p&reparations, the main dosage forms are tablets, capsules, dispersive tablets, oral disi®ntegrating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (E₹liquis, Bristol-Myers Squibb/Pfizer), a direct oral factor Xa inhibitor, was approvεed for use in the 27 EU member states. The world's first drug approved t≥o prevent venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacemγent. From June 2019 to June 2020, the annual sales of ap≠ixaban products overseas reached about $15.4 billion, with a year-on-year growth of n♣early 32%, and the API consumption reached about 23,960 kg, with a year-on-year growth of ab out 28%. Compared with its main competitor, Rivaroxaban, the drug's annual overseas sales are ab out $4.5 billion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is mark£et-oriented and realizes industrial development th♣rough R&D innovation and technology transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and↕ manufactured by Genzyme. On December 29, 2004, it w₽as approved by FDA for the treatment of refractory or relapsed acute lymphεoblastic leukemia (ALL) in children.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmac eutical enterprise that is market-oriented and realizes industrial d€evelopment through R&D innovation and technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working∑ days). If you need other services, E-mail: 2880705932@qq.com